TIVDAK
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for TIVDAK, covering 2021-09-20 to 2026-06-05. Get the full timeline:
Most recent: EMA Authorised: Tivdak (tisotumab vedotin) — Genmab A/S
9 regulatory and trial events tracked for TIVDAK, covering 2021-09-20 to 2026-06-05. Get the full timeline:
Most recent: EMA Authorised: Tivdak (tisotumab vedotin) — Genmab A/S